Jie Ma1, Dong Guo2, Wenjie Miao1, Yangyang Wang1, Lei Yan1, Fengyu Wu1, Chuantao Zhang3, Ran Zhang4, Panli Zuo4, Guangjie Yang5, Zhenguang Wang6. 1. Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, No. 59 Hair Road, Qingdao, Shandong, China. 2. Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. 3. Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. 4. Huiying Medical Technology Co.Ltd, Beijing, China. 5. Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, No. 59 Hair Road, Qingdao, Shandong, China. ygj_2815@qq.com. 6. Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, No. 59 Hair Road, Qingdao, Shandong, China. doctorwzg2002@hotmail.com.
Abstract
PURPOSE: Perineural invasion (PNI) has been recognized as an important prognosis factor in patients with colorectal cancer (CRC). The purpose of this retrospective study was to investigate the value of 18F-FDG PET/CT-based radiomics integrating clinical information, PET/CT features, and metabolic parameters for preoperatively predicting PNI and outcome in non-metastatic CRC and establish an easy-to-use nomogram. METHODS: A total of 131 patients with non-metastatic CRC who undergo PET/CT scan were retrospectively enrolled. Univariate analysis was used to compare the differences between PNI-present and PNI-absent groups. Multivariate logistic regression was performed to select the independent predictors for PNI status. Akaike information criterion (AIC) was used to select the best prediction models for PNI status. CT radiomics signatures (RSs) and PET-RSs were selected by maximum relevance minimum redundancy (mRMR) and the least absolute shrinkage and selection operator algorithm (LASSO) regression and radiomics scores (Rad-scores) were calculated for each patient. The prediction models with or without Rad-score were established. According to the nomogram, nomogram scores (Nomo-scores) were calculated for each patient. The performance of different models was assessed with the area under the curve (AUC), specificity, and sensitivity. The clinical usefulness was assessed by decision curve (DCA). Multivariate Cox regression was used to selected independent predictors of progression-free survival (PFS). RESULTS: Among all the clinical information, PET/CT features, and metabolic parameters, CEA, lymph node metastatic on PET/CT (N stage), and total lesion glycolysis (TLG) were independent predictors for PNI (p < 0.05). Six CT-RSs and 12 PET-RSs were selected as the most valuable factors to predict PNI. The Rad-score calculated with these RSs was significantly different between PNI-present and PNI-absent groups (p < 0.001). The AUC of the constructed model was 0.90 (95%CI: 0.83-0.97) in the training cohort and 0.80 (95%CI: 0.65-0.95) in the test cohort. The nomogram's predicting sensitivity was 0.84 and the specificity was 0.83 in the training cohort. The clinical model's predicting sensitivity and specificity were 0.66 and 0.85 in the training cohort, respectively. Besides, DCA showed that patients with non-metastatic CRC could get more benefit with our model. The results also indicated that N stage, PNI status, and the Nomo-score were independent predictors of PFS in patients with non-metastatic CRC. CONCLUSION: The nomogram, integrating clinical data, PET/CT features, metabolic parameters, and radiomics, performs well in predicting PNI status and is associated with the outcome in patients with non-metastatic CRC.
PURPOSE: Perineural invasion (PNI) has been recognized as an important prognosis factor in patients with colorectal cancer (CRC). The purpose of this retrospective study was to investigate the value of 18F-FDG PET/CT-based radiomics integrating clinical information, PET/CT features, and metabolic parameters for preoperatively predicting PNI and outcome in non-metastatic CRC and establish an easy-to-use nomogram. METHODS: A total of 131 patients with non-metastatic CRC who undergo PET/CT scan were retrospectively enrolled. Univariate analysis was used to compare the differences between PNI-present and PNI-absent groups. Multivariate logistic regression was performed to select the independent predictors for PNI status. Akaike information criterion (AIC) was used to select the best prediction models for PNI status. CT radiomics signatures (RSs) and PET-RSs were selected by maximum relevance minimum redundancy (mRMR) and the least absolute shrinkage and selection operator algorithm (LASSO) regression and radiomics scores (Rad-scores) were calculated for each patient. The prediction models with or without Rad-score were established. According to the nomogram, nomogram scores (Nomo-scores) were calculated for each patient. The performance of different models was assessed with the area under the curve (AUC), specificity, and sensitivity. The clinical usefulness was assessed by decision curve (DCA). Multivariate Cox regression was used to selected independent predictors of progression-free survival (PFS). RESULTS: Among all the clinical information, PET/CT features, and metabolic parameters, CEA, lymph node metastatic on PET/CT (N stage), and total lesion glycolysis (TLG) were independent predictors for PNI (p < 0.05). Six CT-RSs and 12 PET-RSs were selected as the most valuable factors to predict PNI. The Rad-score calculated with these RSs was significantly different between PNI-present and PNI-absent groups (p < 0.001). The AUC of the constructed model was 0.90 (95%CI: 0.83-0.97) in the training cohort and 0.80 (95%CI: 0.65-0.95) in the test cohort. The nomogram's predicting sensitivity was 0.84 and the specificity was 0.83 in the training cohort. The clinical model's predicting sensitivity and specificity were 0.66 and 0.85 in the training cohort, respectively. Besides, DCA showed that patients with non-metastatic CRC could get more benefit with our model. The results also indicated that N stage, PNI status, and the Nomo-score were independent predictors of PFS in patients with non-metastatic CRC. CONCLUSION: The nomogram, integrating clinical data, PET/CT features, metabolic parameters, and radiomics, performs well in predicting PNI status and is associated with the outcome in patients with non-metastatic CRC.
Authors: Paolo Aurello; Giammauro Berardi; Simone Maria Tierno; Gian Luca Rampioni Vinciguerra; Fabio Socciarelli; Giovanni Guglielmo Laracca; Diego Giulitti; Emanuela Pilozzi; Giovanni Ramacciato Journal: Am J Surg Date: 2016-07-29 Impact factor: 2.565
Authors: Mariam B Totonchy; Jennifer M McNiff; Kathleen C Suozzi; David J Leffell; Sean R Christensen Journal: Dermatol Surg Date: 2021-04-01 Impact factor: 3.398
Authors: Stefano Crippa; Ilaria Pergolini; Ammar A Javed; Kim C Honselmann; Matthew J Weiss; Francesca Di Salvo; Richard Burkhart; Giuseppe Zamboni; Giulio Belfiori; Cristina R Ferrone; Corrado Rubini; Jun Yu; Giulia Gasparini; Motaz Qadan; Jin He; Keith D Lillemoe; Carlos Fernandez-Del Castillo; Christopher L Wolfgang; Massimo Falconi Journal: Ann Surg Date: 2020-10-19 Impact factor: 13.787
Authors: Brett Delahunt; Judith D Murray; Allison Steigler; Chris Atkinson; David Christie; Gillian Duchesne; Lars Egevad; David Joseph; John Matthews; Christopher Oldmeadow; Hemamali Samaratunga; Nigel A Spry; John R Srigley; Hubert Hondermarck; James W Denham Journal: Histopathology Date: 2020-04-13 Impact factor: 5.087
Authors: Nelleke P M Brouwer; Amanda C R K Bos; Valery E P P Lemmens; Pieter J Tanis; Niek Hugen; Iris D Nagtegaal; Johannes H W de Wilt; Rob H A Verhoeven Journal: Int J Cancer Date: 2018-09-29 Impact factor: 7.396